Face-it: Health Promotion for Women With Prior Gestational Diabetes

NCT03997773 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 277

Last updated 2024-07-12

No results posted yet for this study

Summary

This project focuses on evaluating a health promotion intervention among families where the mother has prior gestational diabetes mellitus (GDM) in the first year after delivery. The intervention focuses on the individual, family and health system levels. The aim is to increase quality of life and reduce the risk of type 2 diabetes among women with prior GDM and their families.

Conditions

Interventions

BEHAVIORAL

Face-it Intervention

The Face-it intervention is a health promotion intervention consisting of 3 major components: 1) active involvement of health visitors, 2) digital health technology and coaching, and 3) a structured cross-sectoral communication system in the healthcare system. The intervention will begin at time approx. 3 months (after the baseline data collection, i.e. 10-14 weeks postpartum), and continues until 12 months

Sponsors & Collaborators

  • Steno Diabetes Center Odense

    collaborator OTHER
  • Aarhus University Hospital

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Aarhus Municipality, Denmark

    collaborator OTHER
  • Odense Municipality

    collaborator UNKNOWN
  • Copenhagen Municipality, Denmark

    collaborator OTHER_GOV
  • Liva Healthcare A/S

    collaborator UNKNOWN
  • Steno Diabetes Center Copenhagen

    lead OTHER

Principal Investigators

  • Helle Terkildsen Maindal, MPH, PhD · Steno Diabetes Center Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-16
Primary Completion
2023-06-06
Completion
2023-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03997773 on ClinicalTrials.gov